Annals of the Rheumatic Diseases: 80 (8)

Viewpoint

Primary and secondary non-response: in need of operational definitions in observational studies (21 April, 2021)
Enriqueta Vallejo-Yagüe, Edward C Keystone, Sreemanjari Kandhasamy, Raphael Micheroli, Axel Finckh, Andrea Michelle Burden

Rheumatoid arthritis

Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial (2 April, 2021)
Veerle Stouten, René Westhovens, Sofia Pazmino, Diederik De Cock, Kristien Van der Elst, Johan Joly, Delphine Bertrand, Patrick Verschueren
Tenosynovitis has a high sensitivity for early ACPA-positive and ACPA-negative RA: a large cross-sectional MRI study (5 February, 2021)
Xanthe Marijn Edmée Matthijssen, Fenne Wouters, Navkiran Sidhu, Ellis Niemantsverdriet, Annette van der Helm-van Mil
Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trial (2 April, 2021)
Ho So, Isaac T Cheng, Sze-Lok Lau, Evelyn Chow, Tommy Lam, Vivian W Hung, Edmund K Li, James F Griffith, Vivian W Lee, Lin Shi, Junbin Huang, Kitty Yan Kwok, Cheuk-Wan Yim, Tena K Li, Vincent Lo, Jolie Lee, Jack Jock-Wai Lee, Ling Qin, Lai-Shan Tam
Circulating blood metabolite trajectories and risk of rheumatoid arthritis among military personnel in the Department of Defense Biorepository (22 March, 2021)
Karen H Costenbader, Michael DiIorio, Su H Chu, Jing Cui, Jeffrey A Sparks, Bing Lu, LauraKay Moss, Lindsay Kelmenson, Marie Feser, Jess Edison, Clary Clish, Jessica Lasky-Su, Kevin D Deane, Elizabeth W Karlson
Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020 (2 April, 2021) Free
Wenhui Xie, Hong Huang, Guangtao Li, Yanjie Hao, Yanni Gui, Yu Wang, Xuerong Deng, Juan Zhao, Yan Geng, LanLan Ji, Xiaohui Zhang, Zhibo Song, Zhuoli Zhang

Spondyloarthritis

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study (27 April, 2021)
Atul Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, Xenofon Baraliakos, Lianne S Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang, Oluwaseyi Dina, Lara Fallon, Keith S Kanik, Désirée van der Heijde
Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial (7 April, 2021)
James Cheng-Chung Wei, Tae-Hwan Kim, Mitsumasa Kishimoto, Naoki Ogusu, Haeyoun Jeong, Shigeto Kobayashi
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y) (6 May, 2021)
Robert BM Landewé, Lianne S Gensler, Denis Poddubnyy, Proton Rahman, Maja Hojnik, Xiaoqi Li, Soyi Liu Leage, David Adams, Hilde Carlier, Filip Van den Bosch

Sjögren's syndrome

Lysosome-associated membrane protein 3 misexpression in salivary glands induces a Sjögren’s syndrome-like phenotype in mice (3 March, 2021)
Hiroyuki Nakamura, Tsutomu Tanaka, Thomas Pranzatelli, Youngmi Ji, Hongen Yin, Paola Perez, Sandra A Afione, Shyh-Ing Jang, Corrine Goldsmith, Chang Yu Zheng, William D Swaim, Blake M Warner, Noriyuki Hirata, Masayuki Noguchi, Tatsuya Atsumi, John A Chiorini

Systemic sclerosis

Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes (1 April, 2021)
Marialbert Acosta-Herrera, Martin Kerick, Elena Lopéz-Isac, Shervin Assassi, Lorenzo Beretta, Carmen Pilar Simeón-Aznar, Norberto Ortego-Centeno, International SSc Group, Susanna M Proudman, Australian Scleroderma Interest Group (ASIG), Nicolas Hunzelmann, Gianluca Moroncini, Jeska K de Vries-Bouwstra, Gisela Orozco, Anne Barton, Ariane L Herrick, Chikashi Terao, Yannick Allanore, Matthew A Brown, Timothy RDJ Radstake, Carmen Fonseca, Christopher P Denton, Maureen D Mayes, Javier Martin
X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc) (26 April, 2021)
Christina Bergmann, Ludwig Hallenberger, Sara Chenguiti Fakhouri, Benita Merlevede, Amelie Brandt, Clara Dees, Honglin Zhu, Ariella Zehender, Xiang Zhou, Annemarie Schwab, Chih-Wei Chen, Andrea Hermina Györfi, Alexandru Emil Matei, Debomita Chakraborty, Thuong Trinh-Minh, Simon Rauber, Roland Coras, Aline Bozec, Alexander Kreuter, Mirjana Ziemer, Georg Schett, Jörg H W Distler

Autoinflammatory disorders

Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis
(31 March, 2021)
Naomi Tsuchida, Yosuke Kunishita, Yuri Uchiyama, Yohei Kirino, Makiko Enaka, Yukie Yamaguchi, Masataka Taguri, Shoji Yamanaka, Kaoru Takase-Minegishi, Ryusuke Yoshimi, Satoshi Fujii, Hideaki Nakajima, Naomichi Matsumoto

Osteoarthritis

Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study (7 May, 2021)
Felix Eckstein, Marc C Hochberg, Hans Guehring, Flavie Moreau, Victor Ona, Asger Reinstrup Bihlet, Inger Byrjalsen, Jeppe Ragnar Andersen, Benjamin Daelken, Oliver Guenther, Christoph Ladel, Martin Michaelis, Philip G Conaghan
Linking chondrocyte and synovial transcriptional profile to clinical phenotype in osteoarthritis (26 April, 2021)
Julia Steinberg, Lorraine Southam, Andreas Fontalis, Matthew J Clark, Raveen L Jayasuriya, Diane Swift, Karan M Shah, Roger A Brooks, Andrew W McCaskie, Jeremy Mark Wilkinson, Eleftheria Zeggini

Miscellaneous

Novel self-amplificatory loop between T cells and tenocytes as a driver of chronicity in tendon disease (10 March, 2021)
Emma Garcia-Melchor, Giacomo Cafaro, Lucy MacDonald, Lindsay A N Crowe, Shatakshi Sood, Michael McLean, Umberto G Fazzi, Iain B McInnes, Moeed Akbar, Neal L Millar

Epidemiology

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study (23 February, 2021)
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling

Letters

Patient research partner involvement in rheumatology clinical trials: analysis of journal articles 2016–2020 (1 March, 2021)
Huixin Wang, Sarah Stewart, Ben Darlow, Ben Horgan, Graham Hosie, Jane Clark, Nicola Dalbeth
Onset of rheumatoid arthritis after COVID-19: coincidence or connected? (1 March, 2021)
Veerle F A M Derksen, Theresa Kissel, Femke B G Lamers-Karnebeek, Arie E van der Bijl, Annemarie C Venhuizen, Tom W J Huizinga, René E M Toes, Anna H E Roukens, Diane van der Woude
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases (23 March, 2021)
Brian J Boyarsky, Jake A Ruddy, Caoilfhionn M Connolly, Michael T Ou, William A Werbel, Jacqueline M Garonzik-Wang, Dorry L Segev, Julie J Paik
Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases (19 March, 2021)
Caoilfhionn M Connolly, Jake A Ruddy, Brian J Boyarsky, Robin K Avery, William A Werbel, Dorry L Segev, Jacqueline Garonzik-Wang, Julie J Paik
SARS-CoV-2 infection among inpatients with systemic lupus erythematosus in France: a nationwide epidemiological study (16 March, 2021)
Arthur Mageau, Geoffrey Aldebert, Damien Van Gysel, Thomas Papo, Jean-François Timsit, Karim Sacre
Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab (4 March, 2021)
Marcia A Friedman, Kevin L Winthrop

Electronic pages

New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS (9 September, 2019) Free
Florence Assan, Raphaele Seror, Xavier Mariette, Gaetane Nocturne
Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS’ by Assan et al
(18 September, 2019) Free
Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson
Role of ANA testing in the classification of patients with systemic lupus erythematosus (20 September, 2019) Free
David S Pisetsky, Diane M Spencer, Brad Rovin, Peter E Lipsky
Response to: ‘Role of ANA testing in the classification of patients with systemic lupus erythematosus’ by Pisetsky et al
(11 October, 2019) Free
Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson
Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients? (16 September, 2019) Free
Huihui Chi, Jialin Teng, Zhihong Wang, Chengde Yang, Yutong Su
Response to: ‘Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?’ by Chi et al
(4 October, 2019) Free
Martin Aringer, Karen H Costenbader, Thomas Dörner, Sindhu R Johnson
Titre-specific positive predictive value of antinuclear antibody patterns (10 October, 2019) Free
Jean-Baptiste Vulsteke, Lieve Van Hoovels, Philippe Willems, Bert Vander Cruyssen, Steven Vanderschueren, Rene Westhovens, Daniel Blockmans, Ellen De Langhe, Xavier Bossuyt
Response to ‘Titre-specific positive predictive value of anti-nuclear antibody patterns’ by Vulsteke et al
(10 October, 2019) Free
Jan Damoiseaux, Luís Eduardo Coelho Andrade, Marvin J Fritzler, Manfred Herold, Maria Infantino, Carlos von Muhlen
Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2 (14 October, 2019) Free
Sheng-Xiao Zhang, Jia Wang, He-Hua Sun, Jia-Qian Zhang, Guang-Ying Liu, Jing Luo, Pei-Feng He, Xiao-Feng Li
Response to: ‘Circulating regulatory T cells were absolutelydecreased in dermatomyositis/polymyositispatients and restored by low-dose IL-2’ by Zhang et al
(14 October, 2019) Free
David Klatzmann
Standardisation of myositis-specific antibodies: where are we today? (3 August, 2019) Free
Michael Mahler, Jean-Baptiste Vulsteke, Xavier Bossuyt, Ellen De Langhe, Minoru Satoh
What is the starting dose of steroid prescribed by rheumatologist in the management of polymyalgia rheumatica? (27 August, 2019) Free
Jean Jacques Dubost, Bruno Pereira, Angelique Fan, Martin Soubrier
Diabetes mellitus in ankylosing spondylitis (6 September, 2019) Free
Kuan-Fu Liao, Yu-Hung Kuo, Shih-Wei Lai
Response to: ‘Diabetes mellitus in ankylosing spondylitis’ by Liao et al
(18 September, 2019) Free
Sylvain Mathieu, Martin Soubrier
Association between ankylosing spondylitis and venous thromboembolism (18 June, 2019) Free
Shih-Wei Lai
Risk of gout flares after vaccination (17 August, 2019) Free
Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao
‘DESIRABLE’ or not? (6 September, 2019) Free
Nupoor Acharya, Arghya Chattopadhyay, Varun Dhir
Retraction: Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis
(6 July, 2021)

Main menu

Table of contents

August 2021 - Volume 80 - 8

Viewpoint

Rheumatoid arthritis

Spondyloarthritis

Sjögren's syndrome

Systemic sclerosis

Autoinflammatory disorders

Osteoarthritis

Miscellaneous

Epidemiology

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

August 2021 - Volume 80 - 8

Viewpoint

Rheumatoid arthritis

Spondyloarthritis

Sjögren's syndrome

Systemic sclerosis

Autoinflammatory disorders

Osteoarthritis

Miscellaneous

Epidemiology

Letters

Electronic pages

Issue Information